MI-ASTERAND-BIOSCIENCE
Asterand Bioscience, the leader in high quality, well-characterized human tissue and human tissue-based research solutions supporting drug discovery and development, announced today a partnership with MolecularMD to combine MolecularMD’s expertise as a provider of molecular diagnostics products and services with Asterand Bio’s drug target and candidate validation capabilities. MolecularMD is a molecular diagnostics company that develops custom clinical trial assays as well as companion diagnostic products, supporting clinical trial services and commercialization of targeted cancer therapies. The partnership creates an end-to-end workflow for biopharma clients and strengthens the companies’ current offerings in assay development & validation, while creating a global footprint for the efficient delivery of clinical trial sample analyses.
“For over 20 years, Asterand Bioscience’s experienced scientists have worked collaboratively with clients to expedite the highest likelihood for clinical success by providing a variety of pre-clinical research services,” said John Canepa, Chief Financial Officer/Chief Operations Officer. “This agreement brings together MolecularMD’s proven track record in clinical assay development and companion diagnostics with Asterand Bio’s human tissue procurement, characterization and research services to provide a comprehensive approach to meet the needs of pharmaceutical, biotechnology and diagnostic companies from validation of biomarkers and targets to assay development, through regulatory and clinical trials.”
“MolecularMD is uniquely suited to assist biopharma clients with our clinical trial and regulatory expertise,” said Dan Snyder, President/Chief Executive Officer, MolecularMD. “I’m excited that Asterand Bio and MolecularMD have joined forces to provide these unique advantages which will help our broad client base accelerate their pipeline decisions and dramatically improve the efficiency of the clinical trial and commercialization workflow.”
Asterand Bio and MolecularMD will both attend Molecular Med Tri-Con 2017, Feb 19-24 at the Moscone North Convention Center, San Francisco, CA, a meeting bringing together over 3,500 drug discovery and development professionals. More information about the partnership can be found at Asterand Bio’s booth #626. Asterand Bio and MolecularMD will both attend the AACR 2017 meeting, April 1-5 at the Walter E. Washington Convention Center in Washington DC, a meeting that highlights the highest level of cancer science and medicine from institutions all over the world. More information about the partnership can be found at Asterand Bio’s booth #1340 and MolecularMD’s booth #3423.
About Asterand Bioscience
Asterand Bioscience is the leading global provider of high quality, well-characterized human tissue and human tissue-based research solutions to drug discovery scientists. Our mission is to provide human-based solutions to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with increased likelihood of clinical success. From our offices in Detroit, MI and Royston, U.K. our employees are focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety.
About MolecularMD
MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. MolecularMD integrates gold-standard and innovative platform technologies with clinical assay design, validation and centralized testing to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170215005195/en/
Contact:
MolecularMD
Fritz Eibel
Senior VP and CMO
Feibel@molecularmd.com
or
Asterand
Bioscience
Cathie G. Miller, PhD
Director of Product Marketing
cathie.miller@asterandbio.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wolters Kluwer survey reveals key drivers of job satisfaction among Dutch accounting professionals6.8.2025 08:00:00 CEST | Press release
Findings highlight the importance of workplace atmosphere, meaningful work, and automation in boosting employee happiness and retention Wolters Kluwer Tax & Accounting Netherlands today released the results of its latest survey, “Work Pressure or Job Satisfaction?”, offering a revealing look into what drives happiness—and frustration—among accounting professionals in the Netherlands. The survey, conducted in May 2025, gathered insights from professionals across a range of roles and firm sizes, providing a snapshot of the sector’s evolving expectations and challenges. “The future of the accounting profession calls for greater focus on employee well-being and educational innovation,” said Jeffrey Smit, Vice President & General Manager, Wolters Kluwer Tax & Accounting, Europe Region West. “True gains come from sustainable employability, future-focused expertise, and job satisfaction. Today’s accountant is no longer just a number-cruncher, but a savvy advisor who brings together data, tech
The GTDC, CONTEXT and IDC Forge Unprecedented Global Alliance to Deliver Technology Sales Data6.8.2025 04:00:00 CEST | Press release
First-of-its-kind collaboration will result in like-for-like, actionable data for IT vendors and distributors across Asia Pacific, North America, Europe, and the Middle East markets Three powerhouse leaders in the global distribution and data intelligence sector are partnering to create the first and only data source that will deliver comprehensive sell-through insights across Asia Pacific, North America, Europe, and the Middle East. The collaboration will deliver the definitive global source of technology sales-through data across key markets, providing vendors and distributors with an unparalleled 360-degree view of market trends. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250805421998/en/ IDC, GTDC and CONTEXT, powerhouse leaders in the global distribution and data intelligence sector, are partnering to create the first and only data source that will deliver comprehensive sell-through insights across Asia Pacific, Nor
The Hackett Group® and Celonis Partner to Accelerate ROI With Unmatched AI + Process Intelligence Solutions5.8.2025 23:18:00 CEST | Press release
The Hackett Group, Inc. (NASDAQ: HCKT), a leading generative artificial intelligence (Gen AI) consultancy and executive advisory firm, today announced a collaboration with Celonis, a global leader in process mining, to deliver intelligent enterprise automation that drives measurable business results at unprecedented speed. Using Celonis process intelligence and The Hackett Group’s AI XPLR™ and ZBrain™ platforms – that leverage The Hackett Group’s globally recognized enterprise benchmarking and business transformation IP – companies can compare their performance against Digital World Class® performance standards. This will allow clients to quickly identify the greatest ROI opportunities and harness unmatched process intelligence and agentic workflow solutions to achieve their value realization objectives. The partnership delivers: Clarity on the right tech investments: Combining The Hackett Group’s industry benchmarks with Celonis process intelligence and its own benchmarks on leading m
IFF Reports Second Quarter 2025 Results5.8.2025 22:26:00 CEST | Press release
Reaffirms Full Year 2025 Financial GuidanceLeverage Reduced to 2.5x; Announces new $500M Share Repurchase AuthorizationEnters into Definitive Agreement to Sell Soy Crush, Concentrates & Lecithin Business; Evaluating Strategic Alternatives for Food Ingredients Segment IFF (NYSE: IFF) reported financial results for the second quarter ended June 30, 2025. Management Commentary “IFF’s second-quarter results reflect the progress we are making to strengthen our business and advance our strategic agenda,” said Erik Fyrwald, CEO of IFF. “Our teams delivered top-line growth and improved profitability, driven by disciplined execution and a strong focus on productivity. We also made strides in reshaping our portfolio by closing the divestitures of Pharma Solutions and Nitrocellulose, and successfully completing our debt tender offering - reducing leverage to 2.5x, ahead of our target and reinforcing our financial position.” “Additionally, we announced the expected divestiture of our soy crush, co
Cooler Master’s MasterHUB Wins Red Dot Award for Design Excellence5.8.2025 21:36:00 CEST | Press release
Modular Control Deck Honored in 2025 Brands & Communication Category Cooler Master, a global leader in innovative thermal solutions and PC hardware, today announced that MasterHUB has won the Red Dot Award in the 2025 Brands & Communication Design category. The Red Dot is an internationally recognized symbol of outstanding design quality, awarded by a jury of global design experts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250805404259/en/ Cooler Master's Award-Winning MasterHUB Stream Deck. This recognition highlights Cooler Master’s FreeForm 2.0 design philosophy, which empowers users to build personalized, modular systems that evolve with their needs. MasterHUB embodies this approach by offering a flexible foundation for streamers, editors, and creatives to shape their own workflows. “MasterHUB was designed to grow with you,” said Matteo Stracciari, General Manager at Cooler Master. “Whether you're mixing audio, edit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom